Ticker Launch

SPAC · Merger completed

Alpha Healthcare Acquisition Corp.

Business combination with Humacyte, Inc.

Alpha Healthcare Acquisition Corp. is a blank-check company (SPAC) that raised $100M in its initial public offering on Sep 18, 2020, listing on Nasdaq Capital Market. It completed its business combination with Humacyte, Inc. on Aug 26, 2021; the combined company is Humacyte, Inc. (HUMA). Ellenoff Grossman & Schole advised the SPAC and White & Case advised the underwriters on the IPO.

Humacyte develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. It is the target of a business combination with a special purpose acquisition company in the healthcare sector.

Status
Merger completed
IPO date
Sep 18, 2020
IPO size
$100M
IPO exchange
Nasdaq Capital Market
Target
Humacyte, Inc. (Legacy Humacyte)
Announced
Feb 17, 2021
Closed
Aug 26, 2021
Combined company
Humacyte, Inc. (HUMA)
SPAC counsel (IPO)
Ellenoff Grossman & Schole
Underwriters' counsel (IPO)
White & Case

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2021